Evidence map›Paper›PMID 42222085›Full record

ReviewFrontiers in endocrinology2026

Unveiling the rare coexistence: thyroid hemiagenesis and thyroid cancer - case series and comprehensive review.

Guiming Fu, Hongxia Zhou, Ting Wan, Yinfeng Li, Zhaohui Wang, Yanjia Hou

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guiming FuDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Hongxia ZhouDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Ting WanDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Yinfeng LiDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Zhaohui WangDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Yanjia HouDepartment of Thyroid-ENT Head & Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid hemiagenesis (THA) is a rare congenital malformation. By contrast, the co-occurrence of thyroid carcinoma (TC) in patients with THA is even rarer. Case reports: We present a detailed account of the diagnosis and treatment of two patients diagnosed with THA complicated by TC. Materials and methods: we performed a comprehensive search of the Results: We identified 32 cases of THA complicated with TC reported in the past 50 years. 5 were male and 27 were female. 24 patients underwent color Doppler ultrasonography (US), 12 received CT scanning, and 19 underwent fine-needle aspiration biopsy (FNAB). A total of 29 patients were treated surgically. Papillary thyroid carcinoma (PTC) accounted for 81.3% of all enrolled cases. Conclusions: The coexistence of THA and TC is exceedingly rare and might potentially be linked to multiple genes. There remains a paucity of data on the recognized incidence and etiology of this condition. Currently, diagnostic approaches to this disease are largely analogous to those for conventional TC. Surgical resection remains the primary treatment for such patients; however, the determination of resection scope remains controversial. It is recommended that surgical strategies be formulated with reference to the clinical guidelines for conventional TC. To date, there have been no comprehensive reports evaluating the surgical complications and long-term therapeutic outcomes of this disease.

Indexed as

Thyroid DysgenesisThyroid GlandThyroid NeoplasmsAdultFemaleHumansMaleMiddle Agedclinical characteristicsepidemiologysurgerythyroid cancerthyroid hemiagenesis

Identifiers

PMID42222085
PMCPMC13215897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.